Showing 1 - 20 results of 33 for search 'Joseph F. Merola', query time: 0.81s
Refine Results
-
1
Psoriatic arthritis for dermatologists by Alice Gottlieb, Joseph F. Merola
Published 2020-10-01
Article -
2
-
3
-
4
Rapid response of refractory subacute cutaneous lupus after single dose anifrolumab by Rebecca G. Gaffney, MD, Joseph F. Merola, MD, MMSc
Published 2024-02-01
Article -
5
-
6
Treatment of recalcitrant lupus erythematosus tumidus with deucravacitinib by Arianna Zhang, BS, Rebecca G. Gaffney, MD, Joseph F. Merola, MD, MMSc
Published 2024-03-01
Article -
7
-
8
Discoid lupus erythematosus of the nail treated with thalidomide by Taylor Harp, DO, Michael J. Woodbury, BS, Joseph F. Merola, MD, MMSc
Published 2023-10-01
Article -
9
-
10
Expert consensus achieved on a working core outcome set for cutaneous lupus erythematosus research in survey following the 5th International Conference on Cutaneous Lupus Erythemat... by Victoria P Werth, Joseph F Merola, Lourdes M Perez-Chada, Arianna J Zhang
Published 2024-02-01
Article -
11
-
12
Ruxolitinib cream for the treatment of cutaneous sarcoidosis by Jeffrey S. Smith, MD, PhD, Michael J. Woodbury, BS, Joseph F. Merola, MD, MMSc
Published 2023-08-01
Article -
13
Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Datab... by Joseph F. Merola, Dhaval Patil, Antton Egana, Andrea Steffens, Noah S. Webb, Alice B. Gottlieb
Published 2023-09-01
Article -
14
-
15
-
16
Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies by Peter C. Taylor, Andrew G. Bushmakin, Joseph C. Cappelleri, Pamela Young, Rebecca Germino, Joseph F. Merola, Gil Yosipovitch
Published 2022-07-01
Article -
17
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis by Steven R. Feldman, Joseph F. Merola, David M. Pariser, Jingchuan Zhang, Yang Zhao, Alan M. Mendelsohn, Alice B. Gottlieb
Published 2022-04-01
Article -
18
-
19
Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program by Alice B. Gottlieb, Russel Burge, William N. Malatestinic, Baojin Zhu, Yunyang Zhao, Julie McCormack, Miriam Kimel, Joseph F. Merola
Published 2023-07-01
Article -
20
Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled... by Joseph F. Merola, April Armstrong, Saakshi Khattri, So Yeon Paek, Byron Padilla, Cuiyong Yue, Huzefa Photowala, Blair Kaplan, Lars Erik Kristensen
Published 2024-12-01
Article